These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 28901724)
1. Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone. Lehtihet M; Andersson A; Börjesson A; Schulze J; Rane A; Ericsson M; Ekström L Drug Test Anal; 2018 Apr; 10(4):723-730. PubMed ID: 28901724 [TBL] [Abstract][Full Text] [Related]
2. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073 [TBL] [Abstract][Full Text] [Related]
3. Urinary steroid profile in females - the impact of menstrual cycle and emergency contraceptives. Mullen JE; Thörngren JO; Schulze JJ; Ericsson M; Gårevik N; Lehtihet M; Ekström L Drug Test Anal; 2017 Jul; 9(7):1034-1042. PubMed ID: 27758048 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of urinary excretion of androgens conjugated to cysteine in human pregnancy by mass spectrometry. Fabregat A; Marcos J; Garrostas L; Segura J; Pozo OJ; Ventura R J Steroid Biochem Mol Biol; 2014 Jan; 139():192-200. PubMed ID: 23410595 [TBL] [Abstract][Full Text] [Related]
5. Disposition of Urinary and Serum Steroid Metabolites in Response to Testosterone Administration in Healthy Women. Elings Knutsson J; Andersson A; Baekken LV; Pohanka A; Ekström L; Hirschberg AL J Clin Endocrinol Metab; 2021 Mar; 106(3):697-707. PubMed ID: 33274381 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of doping biomarkers after administration of a single dose testosterone gel. Mullen J; Börjesson A; Hopcraft O; Schulze JJ; Ericsson M; Rane A; Lehtihet M; Ekström L Drug Test Anal; 2018 May; 10(5):839-848. PubMed ID: 29150907 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration. Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228 [TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal administration of testosterone gel on the urinary steroid profile in hypogonadal men: Implications in antidoping analysis. Iannone M; Palermo A; de la Torre X; Romanelli F; Sansone A; Sansone M; Lenzi A; Botrè F Steroids; 2019 Dec; 152():108491. PubMed ID: 31499075 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. Ponzetto F; Mehl F; Boccard J; Baume N; Rudaz S; Saugy M; Nicoli R Anal Bioanal Chem; 2016 Jan; 408(3):705-19. PubMed ID: 26677027 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians. Okano M; Shiomura S Drug Test Anal; 2024 Jun; 16(6):595-603. PubMed ID: 37848395 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration. Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine. Fabregat A; Marcos J; Segura J; Ventura R; Pozo OJ Drug Test Anal; 2016 Jan; 8(1):110-9. PubMed ID: 25917157 [TBL] [Abstract][Full Text] [Related]
14. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes. Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442 [TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in men. Schulze J; Pettersson-Bohlin K; Thörngren JO; Ekström L Drug Test Anal; 2021 Aug; 13(8):1576-1579. PubMed ID: 33864421 [TBL] [Abstract][Full Text] [Related]
16. Application of multivariate statistics to the Steroidal Module of the Athlete Biological Passport: A proof of concept study. Alladio E; Caruso R; Gerace E; Amante E; Salomone A; Vincenti M Anal Chim Acta; 2016 May; 922():19-29. PubMed ID: 27154828 [TBL] [Abstract][Full Text] [Related]
17. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports. Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264 [TBL] [Abstract][Full Text] [Related]
18. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932 [TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers. Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988 [TBL] [Abstract][Full Text] [Related]
20. A novel ultra-high-performance supercritical fluid chromatography hyphenated to tandem mass spectrometry method for the analysis of urinary endogenous steroids in the anti-doping context. Langer T; Nicoli R; Guillarme D; Schweizer-Grundisch C; Rudaz S; Grabherr S; Kuuranne T; Musenga A J Chromatogr A; 2024 Oct; 1734():465224. PubMed ID: 39191183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]